Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
Article
FDA clears Iridex IQ Laser Systems
Mountain view, Calif. - Iridex Corporation says it has received clearance from the U.S. Food and Drug Administration (FDA) for its IQ Laser Systems, according to BioOptics World.
Mountain view, Calif.
- Iridex Corporation says it has received clearance from the U.S. Food and Drug Administration (FDA) for its IQ Laser Systems, according to BioOptics World.
The clearance is for specific applications in dermatology as well as ophthalmology and ENT/otolaryngology. It covers the Iridex IQ 532 (green laser), IQ 577 (yellow), IQ 630-670 (red) and IQ 810 (infrared) laser products.
Related Videos
Related Content
